These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8894333)

  • 1. Is salmeterol ergogenic?
    Morton AR; Joyce K; Papalia SM; Carroll NG; Fitch KD
    Clin J Sport Med; 1996 Oct; 6(4):220-5. PubMed ID: 8894333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overnight protection by inhaled salmeterol on exercise-induced asthma in children.
    Carlsen KH; Røksund O; Olsholt K; Njå F; Leegaard J; Bratten G
    Eur Respir J; 1995 Nov; 8(11):1852-5. PubMed ID: 8620951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of salmeterol on power output in nonasthmatic athletes.
    McDowell SL; Fleck SJ; Storms WW
    J Allergy Clin Immunol; 1997 Apr; 99(4):443-9. PubMed ID: 9111486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of inhaled salbutamol and salmeterol on lung function and endurance performance in healthy well-trained athletes.
    Carlsen KH; Ingjer F; Kirkegaard H; Thyness B
    Scand J Med Sci Sports; 1997 Jun; 7(3):160-5. PubMed ID: 9200320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between peak power output, muscular strength and cycle time trial performance in triathletes.
    Bentley DJ; Wilson GJ; Davie AJ; Zhou S
    J Sports Med Phys Fitness; 1998 Sep; 38(3):201-7. PubMed ID: 9830826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled bronchodilators on lung function and cycling performance in female athletes with and without exercise-induced bronchoconstriction.
    Koch S; Karacabeyli D; Galts C; MacInnis MJ; Sporer BC; Koehle MS
    J Sci Med Sport; 2015 Sep; 18(5):607-12. PubMed ID: 25156879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salbutamol and high-intensity treadmill running in nonasthmatic highly conditioned athletes.
    Heir T; Stemshaug H
    Scand J Med Sci Sports; 1995 Aug; 5(4):231-6. PubMed ID: 7552768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ergogenic effect of long-term use of high dose salbutamol.
    Dickinson J; Molphy J; Chester N; Loosemore M; Whyte G
    Clin J Sport Med; 2014 Nov; 24(6):474-81. PubMed ID: 24451697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
    Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
    Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of montelukast and salmeterol on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction.
    Steinshamn S; Sandsund M; Sue-Chu M; Bjermer L
    Chest; 2004 Oct; 126(4):1154-60. PubMed ID: 15486377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction.
    Schaanning J; Vilsvik J; Henriksen AH; Bratten G
    Ann Allergy Asthma Immunol; 1996 Jan; 76(1):57-60. PubMed ID: 8564629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response study with high-dose inhaled salmeterol in healthy subjects.
    Maconochie JG; Forster JK
    Br J Clin Pharmacol; 1992 Mar; 33(3):342-5. PubMed ID: 1349491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
    Richter K; Janicki S; Jörres RA; Magnussen H
    Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol and physical performance at -15 degrees C in highly trained nonasthmatic cross-country skiers.
    Sue-Chu M; Sandsund M; Helgerud J; Reinertsen RE; Bjermer L
    Scand J Med Sci Sports; 1999 Feb; 9(1):48-52. PubMed ID: 9974197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of protection by inhaled salmeterol in exercise-induced asthma.
    Anderson SD; Rodwell LT; Du Toit J; Young IH
    Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of exercise induced asthma by inhaled salmeterol xinafoate.
    Green CP; Price JF
    Arch Dis Child; 1992 Aug; 67(8):1014-7. PubMed ID: 1355645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.